Easy, Accurate and Affordable Cancer Screening....Welcome to the Beacon Revolution!

Licensed Cripto-1 Patents, NIH License Number L-282-2014/0

  • U.S. Patent No. 7,078,176
  • PCT Application No. PCT/US02/02225
  • U.S. Provisional Patent Application No. 60/264,643
  • Canadian Patent No. 2,434,694
  • Australian Patent No. 2002236871
  • Europe Patent No. 1370869 (Validated in Germany, France, Italy, Spain, Ireland, Great Britain, Switzerland)
  • Japan Patent No. 3821779





​​



  • Caterina Bianco, Luigi Strizzi, Mario Mancino, Kazuhide Wantanabe, Monica Gonzales, Shin Hamada, David S. Salomon, et al,Regulation of Cripto-1 Signaling and Biological Activity by Caveolin-1 in Mammary Epithelial Cells


  • Kazhuhide Wantanabe, Shin Hamada, Caterina Bianco, Mario Mancino, Tadahiro Nagaoka, Monica Gonzales, Luigi Strizzi, David S. Salomon, Mechanism of Signal Transduction: Requirement of Glycosylphosphatidylinositol Anchor of Cripto-1 for trans Activity as a Nodal Co-receptor



.

Cripto-1

Intellectual Property

Published Literature - Examples